Skip to main content

Archived Comments for: Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain

Back to article

  1. Clarification of study codes

    Edward Whitney, Colorado Division of Workers Compensation

    23 December 2010

    Some clarification is needed. The pregabalin studies are referred to not by author but by a code. I am in possession of Rosenstock et al (reference #15), and I notice that it enrolled 76 patients on pregabalin 100 mg tid, with 70 patients on placebo. I infer that this is “DPN-131,” though I find this code nowhere in the Rosenstock article, nor do I find a key to the code on the website.
    Can this be clarified?

    Competing interests

    None declared